RankAlpha logo
Back to Rankings

PBH

Prestige Consumer HealthcareA
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Fiscal first-quarter revenue rose 6.5% to $265.7 million, with 3.2% organic growth and adjusted EPS of $0.98 versus $0.95 a year earlier. Continued organic growth, successful acquisitions and debt reduction could support a rerating.
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.1.
What can break
Acquisition integration and Pillar5 capacity costs create a material gap between reported and adjusted earnings. [#SEC-8K-2026-08-06]
Momentum
70
Value
66
Sentiment
60
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $50.00 · Bull $60.00 · Bear $39.00Analysis 2026-10-22; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-22 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-10-23

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions

Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $67.25
Why
Momentum70 · Δ7d +26.7
Value66 · Δ7d +0.1
Sentiment60 · Δ7d +1.6
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • Value remains the lead driver in the composite, 7D delta +0.1.

Contradictions & invalidation

  • • Acquisition integration and Pillar5 capacity costs create a material gap between reported and adjusted earnings. [#SEC-8K-2026-08-06]
  • • Clear Eyes supply volatility and a challenging consumer backdrop may offset growth in other categories. [#SEC-8K-2026-08-06]
  • • The outlook increase reflected acquisitions rather than a higher underlying-business forecast.

Catalyst clock

2026-11-05

Fiscal 2027 second-quarter results

Lead driver: Value · See fundamentals
Momentum
70
8% active weight
Current posture
7d trendImproving
Δ7d
+26.7
Δ21d
+55.7
Value
66
47% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-0.9
Sentiment
60
45% active weight
Current posture
7d trendImproving
Δ7d
+1.6
Δ21d
-18.8
Why this grade

Composite grade A. Momentum 70.0 / Value 66.3 / Sentiment 59.7

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-22. Scenario method

B+
Bull case
25%
Probability
Target price
$60.00
Analysis reference price unavailable
Analysis 2026-10-22 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$50.00
Analysis reference price unavailable
Analysis 2026-10-22 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$39.00
Analysis reference price unavailable
Analysis 2026-10-22 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$2.26B
Beta
0.43
Shares Out
47.37M
P/E (TTM)
15.5
P/S (TTM)
2.71
P/FCF (TTM)
11.76
Rev YoY
+6.5%
EPS YoY
-35.7%
Gross Margin
+51.6%
Op Margin
+26.3%
Net Debt
$981.56M
Current Ratio
3.23
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data